Salvatore Sollima

1.9k total citations
24 papers, 858 citations indexed

About

Salvatore Sollima is a scholar working on Infectious Diseases, Epidemiology and Virology. According to data from OpenAlex, Salvatore Sollima has authored 24 papers receiving a total of 858 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Infectious Diseases, 13 papers in Epidemiology and 7 papers in Virology. Recurrent topics in Salvatore Sollima's work include HIV/AIDS drug development and treatment (12 papers), HIV Research and Treatment (7 papers) and HIV/AIDS Research and Interventions (7 papers). Salvatore Sollima is often cited by papers focused on HIV/AIDS drug development and treatment (12 papers), HIV Research and Treatment (7 papers) and HIV/AIDS Research and Interventions (7 papers). Salvatore Sollima collaborates with scholars based in Italy, Switzerland and United States. Salvatore Sollima's co-authors include Spinello Antinori, Massimo Galli, Laura Milazzo, Mario Corbellino, Fulvio Adorni, Teresa Bini, Carlo Parravicini, Antonella d’Arminio Monforte, Elisabetta Chiesa and C Abeli and has published in prestigious journals such as AIDS, Journal of Antimicrobial Chemotherapy and Medicine.

In The Last Decade

Salvatore Sollima

24 papers receiving 835 citations

Peers

Salvatore Sollima
Eddie Louie United States
Katherine M. Knapp United States
J. P. Chave Switzerland
Laurie A. Proia United States
Alan Taege United States
Salvatore Sollima
Citations per year, relative to Salvatore Sollima Salvatore Sollima (= 1×) peers Juliette Pavie

Countries citing papers authored by Salvatore Sollima

Since Specialization
Citations

This map shows the geographic impact of Salvatore Sollima's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Salvatore Sollima with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Salvatore Sollima more than expected).

Fields of papers citing papers by Salvatore Sollima

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Salvatore Sollima. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Salvatore Sollima. The network helps show where Salvatore Sollima may publish in the future.

Co-authorship network of co-authors of Salvatore Sollima

This figure shows the co-authorship network connecting the top 25 collaborators of Salvatore Sollima. A scholar is included among the top collaborators of Salvatore Sollima based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Salvatore Sollima. Salvatore Sollima is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Cattaneo, Dario, Salvatore Sollima, Paola Meraviglia, et al.. (2020). Dolutegravir-Based Antiretroviral Regimens for HIV Liver Transplant Patients in Real-Life Settings. Drugs in R&D. 20(2). 155–160. 4 indexed citations
2.
Milazzo, Laura, Lorena van den Bogaart, Salvatore Sollima, et al.. (2020). Impact of HCV eradication with direct-acting antiviral agents on serum gamma globulin levels in HCV and HCV/HIV coinfected patients. European Journal of Internal Medicine. 75. 50–54. 1 indexed citations
3.
Pezzani, Maria Diletta, Carlo Parravicini, Angelica Sonzogni, et al.. (2019). Gastrointestinal basidiobolomycosis: An emerging mycosis difficult to diagnose but curable. Case report and review of the literature. Travel Medicine and Infectious Disease. 31. 101378–101378. 24 indexed citations
4.
Milazzo, Laura, C. Magni, Fosca Niero, et al.. (2017). Short article: Retreatment of chronic hepatitis C virus infection after unsuccessful therapy with all-oral direct-acting antiviral regimens: a real-life experience. European Journal of Gastroenterology & Hepatology. 29(11). 1231–1234. 1 indexed citations
5.
Cattaneo, Dario, Massimo Puoti, Salvatore Sollima, et al.. (2016). Reduced raltegravir clearance in HIV-infected liver transplant recipients: an unexpected interaction with immunosuppressive therapy?. Journal of Antimicrobial Chemotherapy. 71(5). 1341–1345. 5 indexed citations
6.
Antinori, Spinello, Laura Milazzo, Salvatore Sollima, Massimo Galli, & Mario Corbellino. (2016). Candidemia and invasive candidiasis in adults: A narrative review. European Journal of Internal Medicine. 34. 21–28. 182 indexed citations
7.
Monti, Giuseppe, Francesco Saccardo, Laura Castelnovo, et al.. (2014). Prevalence of mixed cryoglobulinaemia syndrome and circulating cryoglobulins in a population-based survey: the Origgio study. Autoimmunity Reviews. 13(6). 609–614. 27 indexed citations
8.
Antinori, Spinello, Laurenzia Ferraris, Giovanna Orlando, et al.. (2014). Fungal Endocarditis Observed Over an 8-Year Period and a Review of the Literature. Mycopathologia. 178(1-2). 37–51. 32 indexed citations
9.
Hasson, Hamid, Laura Galli, Giulia Morsica, et al.. (2012). HAART simplification with lopinavir/ritonavir monotherapy in HIV/HCV co-infected patients starting anti-HCV treatment: a randomised pilot study (KaMon study).. PubMed. 35(4). 469–74. 3 indexed citations
10.
Antinori, Spinello, Mario Corbellino, Luca Meroni, et al.. (2012). Aspergillus meningitis: A rare clinical manifestation of central nervous system aspergillosis. Case report and review of 92 cases. Journal of Infection. 66(3). 218–238. 64 indexed citations
11.
12.
Antinori, Spinello, C. Magni, Manuela Nebuloni, et al.. (2006). Histoplasmosis Among Human Immunodeficiency Virus-Infected People in Europe. Medicine. 85(1). 22–36. 62 indexed citations
13.
Antinori, Spinello, et al.. (2006). DisseminatedPenicillium marneffeiInfection in an HIV‐Positive Italian Patient and a Review of Cases Reported Outside Endemic Regions. Journal of Travel Medicine. 13(3). 181–188. 55 indexed citations
14.
Chiesa, Elisabetta, Teresa Bini, Fulvio Adorni, et al.. (2003). Simplification of Protease Inhibitor-Containing Regimens with Efavirenz, Nevirapine or Abacavir: Safety and Efficacy Outcomes. Antiviral Therapy. 8(1). 27–35. 13 indexed citations
15.
Monforte, Antonella d’Arminio, Fulvio Adorni, Luca Meroni, et al.. (2001). Predictive role of the three-month CD4 cell count in the long-term clinical outcome of the first HAART regimen. Biomedicine & Pharmacotherapy. 55(1). 16–22. 4 indexed citations
16.
Sollima, Salvatore, Maurizio Osio, Alessandra Alciati, et al.. (2001). Protease inhibitors and erectile dysfunction. AIDS. 15(17). 2331–2333. 39 indexed citations
17.
Bini, Teresa, Letizia Testa, Elisabetta Chiesa, et al.. (2000). Outcome of a Second-Line Protease Inhibitor–Containing Regimen in Patients Failing or Intolerant of a First Highly Active Antiretroviral Therapy. JAIDS Journal of Acquired Immune Deficiency Syndromes. 24(2). 115–122. 30 indexed citations
18.
Bini, Teresa, Letizia Testa, Elisabetta Chiesa, et al.. (2000). Outcome of a Second-Line Protease Inhibitor–Containing Regimen in Patients Failing or Intolerant of a First Highly Active Antiretroviral Therapy. JAIDS Journal of Acquired Immune Deficiency Syndromes. 24(2). 115–122. 12 indexed citations
19.
Adorni, Fulvio, Barbara Castelnuovo, Teresa Bini, et al.. (1999). CD4 cell counts at the third month of HAART may predict clinical failure. AIDS. 13(13). 1669–1676. 44 indexed citations
20.
Monforte, Antonella d’Arminio, Letizia Testa, Fulvio Adorni, et al.. (1998). Clinical outcome and predictive factors of failure of highly active antiretroviral therapy in antiretroviral-experienced patients in advanced stages of HIV-1 infection. AIDS. 12(13). 1631–1637. 112 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026